TL;DR: Based on CHM meeting minutes, MHRA performance reports, and public reports on MAA submissions/approvals, DCVax-L will be approved between 11/14/24 and 1/31/25. Here's why:
Then you posted:
Contrary to one frequently shared opinion, DCVax-L appears to be moving faster through the process than other drugs.
Then on Feb 4 you posted , asserting early March would be the tail of the normal timeline.
No offense taken, I'm simply sharing information. Mainly to push back against the constant stream of complaints that DCVax-L is somehow behind schedule/receiving different treatment than other applications. For the next ~4.5 weeks, our application is squarely within the "normal" timeframe established by MHRA's recent performance.
And next month you will move the normal timeline again.